# Promoting the production of challenging proteins via induced expression in CHO cells and modified cell-free lysates harboring T7 RNA polymerase and mutant eIF2α

## TL;DR

This paper introduces new methods to improve the production of difficult proteins using modified CHO cells and cell-free systems.

## Contribution

The study introduces a cell-free system with T7 RNA polymerase and mutant eIF2α to enhance protein production without exogenous additives.

## Key findings

- Modified CHO cell lysates with T7 RNA polymerase and mutant eIF2α increased protein yields in cell-free synthesis.
- The Rosa26 site was identified as a potential location for integrating T7 RNA polymerase for cell-based expression.
- The approach allows flexible switching between cell-free and cell-based protein production methods.

## Abstract

Chinese hamster ovary (CHO) cells are crucial in biopharmaceutical production due to their scalability and capacity for human-like post-translational modifications. However, toxic proteins and membrane proteins are often difficult-to-express in living cells. Alternatively, cell-free protein synthesis can be employed. This study explores innovative strategies for enhancing the production of challenging proteins through the modification of CHO cells by investigating both, cell-based and cell-free approaches. A major result in our study involves the integration of a mutant eIF2 translation initiation factor and T7 RNA polymerase into CHO cell lysates for cell-free protein synthesis. This resulted in elevated yields, while eliminating the necessity for exogenous additions during cell-free production, thereby substantially enhancing efficiency. Additionally, we explore the potential of the Rosa26 genomic site for the integration of T7 RNA polymerase and cell-based tetracycline-controlled protein expression. These findings provide promising advancements in bioproduction technologies, offering flexibility to switch between cell-free and cell-based protein production as needed.